We are live on ! Find out more
RC

Rangeley Capital Portfolio holdings

AUM $103M
1-Year Est. Return 77.32%
This Fund
S&P 500
This Quarter Est. Return
-3.19%
1 Year Est. Return
+77.32%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$103M
AUM Growth
-$17.5M
Cap. Flow
-$2.25M
Cap. Flow %
-2.19%
Top 10 Hldgs %
35.28%
Holding
169
New
46
Increased
35
Reduced
35
Closed
32

Top Buys

Rank Stock Value
1
DRVN icon
Driven Brands
DRVN
+$8.81M
2
RVMD icon
Revolution Medicines
RVMD
+$6.74M
3
ICLR icon
Icon
ICLR
+$2.42M
4
TRIP icon
TripAdvisor
TRIP
+$2.21M
5
ELME
Elme Communities
ELME
+$2.17M

Top Sells

Rank Stock Value
1
GDEN
Golden Entertainment
GDEN
+$5.71M
2
CLMT icon
Calumet Specialty Products
CLMT
+$5.34M
3
WBD icon
Warner Bros
WBD
+$4.62M
4
RNAM
Avidity Biosciences
RNAM
+$3.9M
5
RPTX
Repare Therapeutics
RPTX
+$3.35M

Sector Composition

Rank Sector Weight
1 Healthcare 29.22%
2 Consumer Discretionary 17.78%
3 Real Estate 12.14%
4 Financials 8.26%
5 Technology 4.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FWRD icon
26
Forward Air
FWRD
$466M
$1.42M 1.38%
85,000
+9,000
+12% +$219K
WBD icon
27
Warner Bros
WBD
$63.4B
$1.4M 1.36%
51,000
-165,000
-76% -$4.62M
NLOP
28
Net Lease Office Properties
NLOP
$171M
$1.32M 1.29%
114,870
+46,390
+68% +$780K
ELME
29
Elme Communities
ELME
$144M
$1.32M 1.29%
+658,000
New +$2.17M
RVMD icon
30
Revolution Medicines
RVMD
$40B
$1.24M 1.2%
+66,700
New +$6.74M
BCYC
31
Bicycle Therapeutics
BCYC
$276M
$1.08M 1.05%
232,260
+100,260
+76% +$573K
SWKH
32
DELISTED
SWK Holdings
SWKH
$1.07M 1.04%
63,000
– –
KW
33
DELISTED
Kennedy-Wilson Holdings
KW
$1.05M 1.02%
97,000
-245,000
-72% -$2.54M
HOLX
34
DELISTED
Hologic
HOLX
$983K 0.95%
+13,000
New +$977K
HGV icon
35
Hilton Grand Vacations
HGV
$3.98B
$978K 0.95%
25,000
+10,000
+67% +$448K
SEPN
36
Septerna Inc
SEPN
$1.51B
$956K 0.93%
39,800
-26,000
-40% -$683K
WENN
37
Wen Acquisition Corp
WENN
$388M
$865K 0.84%
85,000
+22,470
+36% +$228K
MNRO icon
38
Monro
MNRO
$529M
$840K 0.82%
+52,344
New +$1.02M
KURA icon
39
Kura Oncology
KURA
$901M
$823K 0.8%
101,220
-1,680
-2% -$14.4K
SEM
40
DELISTED
Select Medical
SEM
$815K 0.79%
50,000
-31,072
-38% -$486K
CWAN
41
DELISTED
Clearwater Analytics
CWAN
$662K 0.64%
28,000
-52,000
-65% -$1.23M
DRDB
42
Roman DBDR Acquisition Corp II
DRDB
$325M
$628K 0.61%
60,000
+16,800
+39% +$176K
KROS icon
43
Keros Therapeutics
KROS
$202M
$601K 0.58%
54,400
-42,400
-44% -$655K
NVRI icon
44
Enviri
NVRI
$620M
$549K 0.53%
28,000
+17,333
+162% +$322K
HEPS
45
D-Market Electronic Services & Trading
HEPS
$1.01B
$524K 0.51%
200,000
– –
BHR
46
Braemar Hotels & Resorts
BHR
$157M
$524K 0.51%
222,000
+148,105
+200% +$412K
GPACU
47
General Purpose Acquisition Corp Units
GPACU
$501K 0.49%
50,000
– –
ABVX
48
Abivax
ABVX
$11.2B
$445K 0.43%
4,000
– –
GLUE icon
49
Monte Rosa Therapeutics
GLUE
$1.91B
$444K 0.43%
27,016
-40,484
-60% -$774K
DSGR icon
50
Distribution Solutions Group
DSGR
$1.6B
$442K 0.43%
+16,857
New +$472K
1
2
3 4 5

Similar funds

EFT
Envision Financial Transparency Greensboro, North Carolina $103M AUM
GWL
Generations Wealth LLC Mason, Ohio $103M AUM
CC
Caspian Capital New York $103M AUM
ABLA
Alan B. Lancz & Associates Toledo, Ohio $103M AUM 31.99% 1-Year Est. Return
SPCM
Stoic Point Capital Management Palo Alto, California $103M AUM
OPAM
Olympus Peak Asset Management Greenwich, Connecticut $103M AUM 58.06% 1-Year Est. Return
ES
ETF Store Overland Park, Kansas $103M AUM 15.78% 1-Year Est. Return
IMT
Investment Management Trust Fitchburg, Massachusetts $103M AUM

Rangeley Capital's Q1 2026 Portfolio in Review

As of Q1 2026, Rangeley Capital held 169 positions worth $103M, down 15% from $120M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Rangeley Capital's Q1 2026 filing shows 46 new, 35 increased, 35 reduced and 32 closed positions. Its largest new stake was Driven Brands: 625,500 shares worth $7.89M. The largest sale was Golden Entertainment, an estimated $5.71M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 33% a quarter earlier, followed by Consumer Discretionary and Real Estate.

  • Rangeley Capital's largest Q1 2026 buy was Driven Brands: 625,500 shares worth $7.89M.
  • Rangeley Capital added most to Janux Therapeutics in Q1 2026, an estimated $1.33M increase.
  • Rangeley Capital's biggest Q1 2026 reduction was Calumet Specialty Products, cutting an estimated $5.34M.
  • Rangeley Capital fully exited Golden Entertainment in Q1 2026, selling an estimated $5.71M.
  • Rangeley Capital's ten largest holdings make up 35% of its $103M portfolio in Q1 2026.
  • Rangeley Capital opened 46 new positions and closed 32 in Q1 2026.
  • Rangeley Capital's portfolio value fell 15% quarter-over-quarter to $103M.

Based on Rangeley Capital's 13F filing for Q1 2026, filed 15 May 2026.